The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"Transferase(Phosphotransferase) domain 1
".
FunFam 55: Glycogen synthase kinase-3 beta
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 56 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
30 |
B2LUN4 (/IPI)
F1NPL8 (/IPI)
G1T8E2 (/IPI)
I6ZX61 (/IPI)
I6ZX61 (/IPI)
P18266 (/IPI)
P18431 (/IPI)
P18431 (/IPI)
P49840 (/IPI)
P49840 (/IPI)
(20 more) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
28 |
P18265 (/IDA)
P18266 (/IDA)
P18431 (/IDA)
P18431 (/IDA)
P49840 (/IDA)
P49840 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(18 more) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
23 |
H0ZT29 (/IMP)
H0ZT29 (/IMP)
P18431 (/IMP)
P18431 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(13 more) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
21 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(11 more) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
20 |
P18431 (/TAS)
P18431 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(10 more) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
20 |
P18265 (/IPI)
P18266 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
(10 more) |
Tau-protein kinase activity GO:0050321
Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein.
|
19 |
P18266 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(9 more) |
Beta-catenin binding GO:0008013
Interacting selectively and non-covalently with the beta subunit of the catenin complex.
|
18 |
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
(8 more) |
Protein kinase A catalytic subunit binding GO:0034236
Interacting selectively and non-covalently with one or both of the catalytic subunits of protein kinase A.
|
18 |
P18265 (/IPI)
P49840 (/IPI)
P49840 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
(8 more) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
17 |
P49840 (/NAS)
P49840 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
(7 more) |
Tau protein binding GO:0048156
Interacting selectively and non-covalently with tau protein. tau is a microtubule-associated protein, implicated in Alzheimer's disease, Down Syndrome and ALS.
|
17 |
P49840 (/NAS)
P49840 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
(7 more) |
Tau-protein kinase activity GO:0050321
Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein.
|
17 |
P49840 (/NAS)
P49840 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
(7 more) |
Kinase activity GO:0016301
Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
|
16 |
P18266 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(6 more) |
RNA polymerase II transcription factor binding GO:0001085
Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II.
|
15 |
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
(5 more) |
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
|
15 |
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
(5 more) |
P53 binding GO:0002039
Interacting selectively and non-covalently with one of the p53 family of proteins.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Kinase activity GO:0016301
Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Ubiquitin protein ligase binding GO:0031625
Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
|
15 |
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
(5 more) |
Dynactin binding GO:0034452
Interacting selectively and non-covalently with any part of a dynactin complex; dynactin is a large protein complex that activates dynein-based motor activity.
|
15 |
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
(5 more) |
NF-kappaB binding GO:0051059
Interacting selectively and non-covalently with NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters.
|
15 |
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
P49841 (/IPI)
(5 more) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
5 | Q10452 (/IDA) Q2NL51 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Kinase activity GO:0016301
Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
|
5 | P18266 (/ISS) Q5YJC2 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Protein kinase A catalytic subunit binding GO:0034236
Interacting selectively and non-covalently with one or both of the catalytic subunits of protein kinase A.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
RNA polymerase II transcription factor binding GO:0001085
Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
P53 binding GO:0002039
Interacting selectively and non-covalently with one of the p53 family of proteins.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
3 | P49840 (/IPI) P49840 (/IPI) Q2NL51 (/IPI) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Beta-catenin binding GO:0008013
Interacting selectively and non-covalently with the beta subunit of the catenin complex.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Kinase activity GO:0016301
Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Ubiquitin protein ligase binding GO:0031625
Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Dynactin binding GO:0034452
Interacting selectively and non-covalently with any part of a dynactin complex; dynactin is a large protein complex that activates dynein-based motor activity.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Ionotropic glutamate receptor binding GO:0035255
Interacting selectively and non-covalently with an ionotropic glutamate receptor. Ionotropic glutamate receptors bind glutamate and exert an effect through the regulation of ion channels.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Tau protein binding GO:0048156
Interacting selectively and non-covalently with tau protein. tau is a microtubule-associated protein, implicated in Alzheimer's disease, Down Syndrome and ALS.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Tau-protein kinase activity GO:0050321
Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
NF-kappaB binding GO:0051059
Interacting selectively and non-covalently with NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Dynein complex binding GO:0070840
Interacting selectively and non-covalently with a dynein complex, a protein complex that contains two or three dynein heavy chains and several light chains, and has microtubule motor activity.
|
3 | Q9WV60 (/IPI) Q9WV60 (/IPI) Q9WV60 (/IPI) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
2 | P18266 (/ISS) Q5YJC2 (/ISS) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
2 | P18266 (/IDA) P51136 (/IDA) |
Beta-catenin binding GO:0008013
Interacting selectively and non-covalently with the beta subunit of the catenin complex.
|
2 | H0ZT29 (/IC) H0ZT29 (/IC) |
Tau-protein kinase activity GO:0050321
Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein.
|
2 | P49840 (/TAS) P49840 (/TAS) |
Protein serine/threonine/tyrosine kinase activity GO:0004712
Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
1 | Q10452 (/IDA) |
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
1 | Q10452 (/IDA) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | Q2NL51 (/ISO) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
1 | P18266 (/IPI) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
1 | P18266 (/IPI) |
Ionotropic glutamate receptor binding GO:0035255
Interacting selectively and non-covalently with an ionotropic glutamate receptor. Ionotropic glutamate receptors bind glutamate and exert an effect through the regulation of ion channels.
|
1 | P18266 (/IPI) |
Tau protein binding GO:0048156
Interacting selectively and non-covalently with tau protein. tau is a microtubule-associated protein, implicated in Alzheimer's disease, Down Syndrome and ALS.
|
1 | P18266 (/IDA) |
Tau-protein kinase activity GO:0050321
Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein.
|
1 | Q5YJC2 (/ISS) |
There are 381 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
26 |
P18265 (/IDA)
P18266 (/IDA)
P18431 (/IDA)
P18431 (/IDA)
P49840 (/IDA)
P49840 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(16 more) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
20 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(10 more) |
Positive regulation of autophagy GO:0010508
Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
20 |
P18265 (/ISS)
P18266 (/ISS)
P49840 (/ISS)
P49840 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(10 more) |
Cellular response to interleukin-3 GO:0036016
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-3 stimulus.
|
20 |
P18265 (/ISS)
P18266 (/ISS)
P49840 (/ISS)
P49840 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(10 more) |
Extrinsic apoptotic signaling pathway in absence of ligand GO:0097192
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.
|
20 |
P18265 (/ISS)
P18266 (/ISS)
P49840 (/ISS)
P49840 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(10 more) |
Positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway GO:1901030
Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway.
|
20 |
P18265 (/ISS)
P18266 (/ISS)
P49840 (/ISS)
P49840 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(10 more) |
Peptidyl-threonine phosphorylation GO:0018107
The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
19 |
P49840 (/IDA)
P49840 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(9 more) |
ER overload response GO:0006983
The series of molecular signals generated by the accumulation of normal or misfolded proteins in the endoplasmic reticulum and leading to activation of transcription by NF-kappaB.
|
18 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(8 more) |
Peptidyl-serine phosphorylation GO:0018105
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
|
18 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(8 more) |
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032436
Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
18 |
P49840 (/IMP)
P49840 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(8 more) |
Dopamine receptor signaling pathway GO:0007212
The series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands.
|
17 |
P49840 (/NAS)
P49840 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
(7 more) |
Circadian rhythm GO:0007623
Any biological process in an organism that recurs with a regularity of approximately 24 hours.
|
17 |
P18266 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(7 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
17 |
P49840 (/ISS)
P49840 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(7 more) |
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
|
17 |
P18266 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(7 more) |
Negative regulation of glycogen biosynthetic process GO:0045719
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
|
17 |
P49840 (/TAS)
P49840 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(7 more) |
Excitatory postsynaptic potential GO:0060079
A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
|
17 |
P49840 (/NAS)
P49840 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
P49841 (/NAS)
(7 more) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
17 |
P49840 (/TAS)
P49840 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(7 more) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
17 |
P49840 (/ISS)
P49840 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(7 more) |
Negative regulation of type B pancreatic cell development GO:2000077
Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic B cell development.
|
17 |
P49840 (/TAS)
P49840 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(7 more) |
Negative regulation of glycogen (starch) synthase activity GO:2000466
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
|
17 |
P49840 (/TAS)
P49840 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(7 more) |
Regulation of circadian rhythm GO:0042752
Any process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours.
|
16 |
P18266 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(6 more) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
16 |
A8X5H5 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(6 more) |
Regulation of long-term synaptic potentiation GO:1900271
Any process that modulates the frequency, rate or extent of long-term synaptic potentiation.
|
16 |
P18266 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(6 more) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Positive regulation of cell-matrix adhesion GO:0001954
Any process that activates or increases the rate or extent of cell adhesion to an extracellular matrix.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Glycogen metabolic process GO:0005977
The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Positive regulation of mitochondrion organization GO:0010822
Any process that increases the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a mitochondrion.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Wnt signaling pathway GO:0016055
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Hippocampus development GO:0021766
The progression of the hippocampus over time from its initial formation until its mature state.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Establishment of cell polarity GO:0030010
The specification and formation of anisotropic intracellular organization or cell growth patterns.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Establishment of cell polarity GO:0030010
The specification and formation of anisotropic intracellular organization or cell growth patterns.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Maintenance of cell polarity GO:0030011
The maintenance of established anisotropic intracellular organization or cell growth patterns.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Maintenance of cell polarity GO:0030011
The maintenance of established anisotropic intracellular organization or cell growth patterns.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Regulation of axon extension GO:0030516
Any process that modulates the rate, direction or extent of axon extension.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Neuron projection development GO:0031175
The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Negative regulation of protein complex assembly GO:0031333
Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex assembly.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032436
Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
15 |
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
(5 more) |
Negative regulation of phosphoprotein phosphatase activity GO:0032515
Any process that stops or reduces the activity of a phosphoprotein phosphatase.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Regulation of microtubule-based process GO:0032886
Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Regulation of protein binding GO:0043393
Any process that modulates the frequency, rate or extent of protein binding.
|
15 |
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
A0A0D9R447 (/IMP)
(5 more) |
Positive regulation of GTPase activity GO:0043547
Any process that activates or increases the activity of a GTPase.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
15 |
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
(5 more) |
Protein autophosphorylation GO:0046777
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Positive regulation of protein export from nucleus GO:0046827
Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Regulation of dendrite morphogenesis GO:0048814
Any process that modulates the frequency, rate or extent of dendrite morphogenesis.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Regulation of axonogenesis GO:0050770
Any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Regulation of microtubule cytoskeleton organization GO:0070507
Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Negative regulation of calcineurin-NFAT signaling cascade GO:0070885
Any process that stops, prevents, or reduces the frequency, rate or extent of the calcineurin-NFAT signaling cascade.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Superior temporal gyrus development GO:0071109
The process whose specific outcome is the progression of the superior temporal gyrus over time, from its formation to the mature structure. The superior temporal gyrus is a portion of the cerebral cortex that extends from the lateral sulcus to the superior temporal sulcus.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
15 |
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
P49841 (/IC)
(5 more) |
Neuron projection organization GO:0106027
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a prolongation or process extending from a neuron, e.g. an axon, or a dendrite.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Regulation of microtubule anchoring at centrosome GO:0150101
Any process that modulates the frequency, rate or extent of microtubule anchoring at centrosome.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Regulation of cellular response to heat GO:1900034
Any process that modulates the frequency, rate or extent of cellular response to heat.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Negative regulation of protein localization to nucleus GO:1900181
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to nucleus.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Negative regulation of protein acetylation GO:1901984
Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Negative regulation of dopaminergic neuron differentiation GO:1904339
Any process that stops, prevents or reduces the frequency, rate or extent of dopaminergic neuron differentiation.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Positive regulation of protein localization to centrosome GO:1904781
Any process that activates or increases the frequency, rate or extent of protein localization to centrosome.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Beta-catenin destruction complex assembly GO:1904885
The aggregation, arrangement and bonding together of a set of components to form a beta-catenin destruction complex.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Beta-catenin destruction complex disassembly GO:1904886
The disaggregation of a beta-catenin destruction complex into its constituent components.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Regulation of synaptic vesicle exocytosis GO:2000300
Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.
|
15 |
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
(5 more) |
Regulation of synaptic vesicle exocytosis GO:2000300
Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Regulation of synaptic vesicle exocytosis GO:2000300
Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.
|
15 |
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(5 more) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
6 | P18431 (/IMP) P18431 (/IMP) Q9U2Q9 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
5 | P18266 (/ISS) Q5YJC2 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Circadian rhythm GO:0007623
Any biological process in an organism that recurs with a regularity of approximately 24 hours.
|
5 | P18431 (/IMP) P18431 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Regulation of circadian rhythm GO:0042752
Any process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours.
|
5 | P18431 (/IMP) P18431 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Negative regulation of calcineurin-NFAT signaling cascade GO:0070885
Any process that stops, prevents, or reduces the frequency, rate or extent of the calcineurin-NFAT signaling cascade.
|
5 | P18266 (/ISS) Q5YJC2 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
|
4 | Q9IBD2 (/IMP) Q9IBD3 (/IMP) Q9YH60 (/IMP) Q9YH61 (/IMP) |
Regulation of gene expression by genetic imprinting GO:0006349
Heritable alterations in the activity of a gene that depend on whether it passed through the paternal or the maternal germline, but that are not encoded by DNA itself.
|
4 | Q2NL51 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
4 | Q10452 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Insulin receptor signaling pathway GO:0008286
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
|
4 | Q2NL51 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Positive regulation of autophagy GO:0010508
Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
4 | Q2NL51 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
4 | Q2NL51 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
4 | P51136 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
4 | Q2NL51 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
4 | Q2NL51 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Peptidyl-serine phosphorylation GO:0018105
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
|
4 | Q2NL51 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Peptidyl-threonine phosphorylation GO:0018107
The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Neuron projection development GO:0031175
The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
4 | P18266 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032436
Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Cellular response to interleukin-3 GO:0036016
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-3 stimulus.
|
4 | Q2NL51 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Hypermethylation of CpG island GO:0044027
An increase in the epigenetic methylation of cytosine and adenosine residues in a CpG island in DNA. CpG islands are genomic regions that contain a high frequency of the CG dinucleotide and are often associated with the transcription start site of genes.
|
4 | Q2NL51 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
4 | Q2NL51 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
4 | Q2NL51 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Extrinsic apoptotic signaling pathway in absence of ligand GO:0097192
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.
|
4 | Q2NL51 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway GO:1901030
Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway.
|
4 | Q2NL51 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
4 | P18266 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Negative regulation of dendrite development GO:2000171
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Re-entry into mitotic cell cycle GO:0000320
The resumption of the mitotic cell division cycle by cells that were in a quiescent or other non-dividing state.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Regulation of cell growth GO:0001558
Any process that modulates the frequency, rate, extent or direction of cell growth.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of cell-matrix adhesion GO:0001954
Any process that activates or increases the rate or extent of cell adhesion to an extracellular matrix.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Glycogen metabolic process GO:0005977
The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
ER overload response GO:0006983
The series of molecular signals generated by the accumulation of normal or misfolded proteins in the endoplasmic reticulum and leading to activation of transcription by NF-kappaB.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Cytoskeleton organization GO:0007010
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures.
|
3 | Q9WV60 (/TAS) Q9WV60 (/TAS) Q9WV60 (/TAS) |
Establishment or maintenance of cell polarity GO:0007163
Any cellular process that results in the specification, formation or maintenance of anisotropic intracellular organization or cell growth patterns.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Axonogenesis GO:0007409
De novo generation of a long process of a neuron, including the terminal branched region. Refers to the morphogenesis or creation of shape or form of the developing axon, which carries efferent (outgoing) action potentials from the cell body towards target cells.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Myoblast fusion GO:0007520
A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Myoblast fusion GO:0007520
A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Response to zinc ion GO:0010043
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of autophagy GO:0010508
Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Negative regulation of cardiac muscle hypertrophy GO:0010614
Any process that decreases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Positive regulation of mitochondrion organization GO:0010822
Any process that increases the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a mitochondrion.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of mitochondrial membrane potential GO:0010918
Any process that activates or increases the frequency, rate or extent of establishment or extent of a mitochondrial membrane potential, the electric potential existing across any mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of neuron projection development GO:0010975
Any process that modulates the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Negative regulation of neuron maturation GO:0014043
Any process that stops, prevents, or reduces the frequency, rate or extent of neuron maturation.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Myotube differentiation GO:0014902
The process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotube differentiation starts with myoblast fusion and the appearance of specific cell markers (this is the cell development step). Then individual myotubes can fuse to form bigger myotubes and start to contract. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Wnt signaling pathway GO:0016055
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Phosphorylation GO:0016310
The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Peptidyl-serine phosphorylation GO:0018105
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Hippocampus development GO:0021766
The progression of the hippocampus over time from its initial formation until its mature state.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Establishment of cell polarity GO:0030010
The specification and formation of anisotropic intracellular organization or cell growth patterns.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Maintenance of cell polarity GO:0030011
The maintenance of established anisotropic intracellular organization or cell growth patterns.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of axon extension GO:0030516
Any process that modulates the rate, direction or extent of axon extension.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Neuron projection development GO:0031175
The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of protein complex assembly GO:0031333
Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex assembly.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of TOR signaling GO:0032007
Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032436
Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Regulation of microtubule-based process GO:0032886
Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Regulation of microtubule-based process GO:0032886
Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of osteoblast proliferation GO:0033690
Any process that activates or increases the rate or extent of osteoblast proliferation.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of smooth muscle cell apoptotic process GO:0034392
Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Protein localization to microtubule GO:0035372
A process in which a protein is transported to, or maintained at, a microtubule.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Cellular response to hepatocyte growth factor stimulus GO:0035729
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hepatocyte growth factor stimulus.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Hepatic stellate cell activation GO:0035733
A change in the morphology or behavior of a hepatic stellate cell resulting from exposure to a cytokine, chemokine, hormone, cellular ligand or soluble factor.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Proteasome-mediated ubiquitin-dependent protein catabolic process GO:0043161
The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
3 | P18265 (/ISS) P49840 (/ISS) P49840 (/ISS) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of GTPase activity GO:0043547
Any process that activates or increases the activity of a GTPase.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Fat cell differentiation GO:0045444
The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Regulation of osteoblast differentiation GO:0045667
Any process that modulates the frequency, rate or extent of osteoblast differentiation.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of osteoclast differentiation GO:0045672
Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
3 | P18266 (/IMP) P18431 (/IMP) P18431 (/IMP) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of axon extension GO:0045773
Any process that activates or increases the frequency, rate or extent of axon extension.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Protein autophosphorylation GO:0046777
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of protein export from nucleus GO:0046827
Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Bone remodeling GO:0046849
The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of neuronal synaptic plasticity GO:0048168
A process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of dendrite morphogenesis GO:0048814
Any process that modulates the frequency, rate or extent of dendrite morphogenesis.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of axonogenesis GO:0050770
Any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of dendrite morphogenesis GO:0050774
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of nitric-oxide synthase activity GO:0051001
Any process that stops or reduces the activity of the enzyme nitric-oxide synthase.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
|
3 | Q9WV60 (/IGI) Q9WV60 (/IGI) Q9WV60 (/IGI) |
Cell growth involved in cardiac muscle cell development GO:0061049
The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress GO:0070059
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Regulation of microtubule cytoskeleton organization GO:0070507
Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
|
3 | P18266 (/IMP) P18431 (/IMP) P18431 (/IMP) |
Regulation of microtubule cytoskeleton organization GO:0070507
Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of calcineurin-NFAT signaling cascade GO:0070885
Any process that stops, prevents, or reduces the frequency, rate or extent of the calcineurin-NFAT signaling cascade.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Superior temporal gyrus development GO:0071109
The process whose specific outcome is the progression of the superior temporal gyrus over time, from its formation to the mature structure. The superior temporal gyrus is a portion of the cerebral cortex that extends from the lateral sulcus to the superior temporal sulcus.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of osteoclast proliferation GO:0090290
Any process that increases the rate, frequency, or extent of the multiplication or reproduction of osteoclasts, resulting in the expansion of an osteoclast cell population.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Hepatocyte apoptotic process GO:0097284
Any apoptotic process in a hepatocyte, the main structural component of the liver.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of neurotransmitter receptor localization to postsynaptic specialization membrane GO:0098696
Any process that modulates the frequency, rate or extent of neurotransmitter receptor localization to postsynaptic specialization membrane.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of modification of postsynaptic structure GO:0099159
Any process that modulates the frequency, rate or extent of modification of postsynaptic structure.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Neuron projection organization GO:0106027
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a prolongation or process extending from a neuron, e.g. an axon, or a dendrite.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of microtubule anchoring at centrosome GO:0150101
Any process that modulates the frequency, rate or extent of microtubule anchoring at centrosome.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of protein localization to nucleus GO:1900181
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to nucleus.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of long-term synaptic potentiation GO:1900271
Any process that modulates the frequency, rate or extent of long-term synaptic potentiation.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of protein acetylation GO:1901984
Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of dopaminergic neuron differentiation GO:1904339
Any process that stops, prevents or reduces the frequency, rate or extent of dopaminergic neuron differentiation.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Negative regulation of protein localization to centrosome GO:1904780
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to centrosome.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Positive regulation of protein localization to centrosome GO:1904781
Any process that activates or increases the frequency, rate or extent of protein localization to centrosome.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Regulation of synaptic vesicle exocytosis GO:2000300
Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of excitatory postsynaptic potential GO:2000463
Any process that enhances the establishment or increases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of DNA biosynthetic process GO:2000573
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Positive regulation of cardiac muscle cell differentiation GO:2000727
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Positive regulation of stem cell differentiation GO:2000738
Any process that activates or increases the frequency, rate or extent of stem cell differentiation.
|
3 | Q9WV60 (/IMP) Q9WV60 (/IMP) Q9WV60 (/IMP) |
Negative regulation of neuron migration GO:2001223
Any process that stops, prevents or reduces the frequency, rate or extent of neuron migration.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
2 | Q9IBD2 (/IMP) Q9YH60 (/IMP) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
2 | H0ZT29 (/IMP) H0ZT29 (/IMP) |
Regulation of systemic arterial blood pressure GO:0003073
The process that modulates the force with which blood travels through the systemic arterial circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Heart jogging GO:0003146
The morphogenetic process in which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
|
2 | Q9IBD2 (/IMP) Q9YH60 (/IMP) |
Cardiac left ventricle morphogenesis GO:0003214
The process in which the left cardiac ventricle is generated and organized.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Epithelial cell morphogenesis GO:0003382
The change in form that occurs when an epithelial cell progresses from its initial formation to its mature state.
|
2 | P18431 (/IGI) P18431 (/IGI) |
Epithelial cell morphogenesis GO:0003382
The change in form that occurs when an epithelial cell progresses from its initial formation to its mature state.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
2 | P83101 (/ISS) Q5YJC2 (/ISS) |
Spindle organization GO:0007051
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the spindle, the array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during DNA segregation and serves to move the duplicated chromosomes apart.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Female meiotic nuclear division GO:0007143
A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the female germline.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Segment polarity determination GO:0007367
Division of the 14 parasegments of the embryo into anterior and posterior compartments; exemplified by the actions of the segment polarity gene products.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
2 | P18431 (/TAS) P18431 (/TAS) |
Rhythmic behavior GO:0007622
The specific behavior of an organism that recur with measured regularity.
|
2 | P18431 (/TAS) P18431 (/TAS) |
Circadian rhythm GO:0007623
Any biological process in an organism that recurs with a regularity of approximately 24 hours.
|
2 | P18431 (/TAS) P18431 (/TAS) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | H0ZT29 (/IMP) H0ZT29 (/IMP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | H0ZT29 (/IMP) H0ZT29 (/IMP) |
Insulin receptor signaling pathway GO:0008286
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Olfactory learning GO:0008355
Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs in response to (repeated) exposure to an olfactory cue.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Chaeta morphogenesis GO:0008407
The process in which the anatomical structures of the chaeta are generated and organized. A chaeta is a sensory multicellular cuticular outgrowth of a specifically differentiated cell.
|
2 | P18431 (/NAS) P18431 (/NAS) |
Imaginal disc-derived wing margin morphogenesis GO:0008587
The process in which the anatomical structures of the imaginal disc-derived wing margin are generated and organized. The wing margin is a strip of cells in the third instar disc at the boundary between the presumptive dorsal and ventral surfaces of the wing blade.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Entrainment of circadian clock GO:0009649
The synchronization of a circadian rhythm to environmental time cues such as light.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
2 | Q9IBD3 (/IGI) Q9YH61 (/IGI) |
Negative regulation of UDP-glucose catabolic process GO:0010905
Any process that decreases the rate, frequency or extent of UDP-glucose catabolism. UDP-glucose catabolic processes are the chemical reactions and pathways resulting in the breakdown of UDP-glucose, uridinediphosphoglucose, a substance composed of glucose in glycosidic linkage with uridine diphosphate.
|
2 | P49840 (/IC) P49840 (/IC) |
Peptidyl-serine phosphorylation GO:0018105
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
|
2 | P18266 (/ISS) Q5YJC2 (/ISS) |
Chaeta development GO:0022416
The process whose specific outcome is the progression of a chaeta over time, from its formation to the mature structure. A chaeta is a sensory multicellular cuticular outgrowth of a specifically differentiated cell.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Regulation of proteolysis GO:0030162
Any process that modulates the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Pseudocleavage involved in syncytial blastoderm formation GO:0030589
Formation of furrows in the cytoplasm between nuclei during cell cycles in embryos that contribute to the formation of the syncytial blastoderm. An example of this process is found in Drosophila melanogaster.
|
2 | P18431 (/NAS) P18431 (/NAS) |
Ovarian follicle cell development GO:0030707
The process that occurs during oogenesis involving the ovarian follicle cells, somatic cells which surround the germ cells of an ovary. An example of this is found in Drosophila melanogaster.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
2 | P49840 (/IMP) P49840 (/IMP) |
Negative regulation of TOR signaling GO:0032007
Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process GO:0032436
Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Cellular response to insulin stimulus GO:0032869
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
2 | P49840 (/IMP) P49840 (/IMP) |
Regulation of microtubule-based process GO:0032886
Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton.
|
2 | P18266 (/ISS) Q5YJC2 (/ISS) |
Somatic stem cell population maintenance GO:0035019
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Social behavior GO:0035176
Behavior directed towards society, or taking place between members of the same species. Occurs predominantly, or only, in individuals that are part of a group.
|
2 | H0ZT29 (/IMP) H0ZT29 (/IMP) |
Chitin-based larval cuticle pattern formation GO:0035293
The process that gives rise to the patterns of cell differentiation in the chitin-based larval cuticle. An example of this is found in Drosophila melanogaster.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Wing and notum subfield formation GO:0035309
The regionalization process that subdivides the wing imaginal disc into the wing and notum (body wall) subfields, thus determining whether cells ultimately differentiate wing or notum-specific structures.
|
2 | P18431 (/IMP) P18431 (/IMP) |
IRE1-mediated unfolded protein response GO:0036498
A series of molecular signals mediated by the endoplasmic reticulum stress sensor IRE1 (Inositol-requiring transmembrane kinase/endonuclease). Begins with activation of IRE1 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. One target of activated IRE1 is the transcription factor HAC1 in yeast, or XBP1 in mammals; IRE1 cleaves an intron of a mRNA coding for HAC1/XBP1 to generate an activated HAC1/XBP1 transcription factor, which controls the up regulation of UPR-related genes. At least in mammals, IRE1 can also signal through additional intracellular pathways including JNK and NF-kappaB.
|
2 | P49840 (/TAS) P49840 (/TAS) |
Regulation of protein import into nucleus GO:0042306
Any process that modulates the frequency, rate or extent of movement of proteins from the cytoplasm to the nucleus.
|
2 | P18431 (/TAS) P18431 (/TAS) |
Negative regulation of JUN kinase activity GO:0043508
Any process that stops, prevents, or reduces the frequency, rate or extent of JUN kinase activity.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
2 | P18265 (/IMP) P18266 (/IMP) |
Locomotor rhythm GO:0045475
The rhythm of the locomotor activity of an organism during its 24 hour activity cycle.
|
2 | P18431 (/NAS) P18431 (/NAS) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
2 | P49840 (/NAS) P49840 (/NAS) |
Positive regulation of heart contraction GO:0045823
Any process that activates or increases the frequency, rate or extent of heart contraction.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Positive regulation of mitotic metaphase/anaphase transition GO:0045842
Any process that activates or increases the frequency, rate or extent of the cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Negative regulation of smoothened signaling pathway GO:0045879
Any process that stops, prevents, or reduces the frequency, rate or extent of smoothened signaling.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Negative regulation of smoothened signaling pathway GO:0045879
Any process that stops, prevents, or reduces the frequency, rate or extent of smoothened signaling.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Negative regulation of synaptic growth at neuromuscular junction GO:0045886
Any process that stops, prevents, or reduces the frequency, rate or extent of synaptic growth at neuromuscular junction.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Negative regulation of glucose import GO:0046325
Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
2 | P49840 (/IMP) P49840 (/IMP) |
Negative regulation of insulin receptor signaling pathway GO:0046627
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Negative regulation of insulin receptor signaling pathway GO:0046627
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
|
2 | P49840 (/IMP) P49840 (/IMP) |
Habituation GO:0046959
A decrease in a behavioral response to a repeated stimulus. This is exemplified by the failure of a person to show a startle response to a loud noise that has been repeatedly presented.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Oogenesis GO:0048477
The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Synaptic growth at neuromuscular junction GO:0051124
The growth of a synapse at a neuromuscular junction, the site of apposition of a motor end plate and the subneural cleft of the skeletal muscle fiber that it innervates.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Cardiac muscle cell development GO:0055013
The process whose specific outcome is the progression of a cardiac muscle cell over time, from its formation to the mature state.
|
2 | Q9IBD3 (/IMP) Q9YH61 (/IMP) |
Negative regulation of cell growth involved in cardiac muscle cell development GO:0061052
Any process that decreases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Regulation of calcineurin-NFAT signaling cascade GO:0070884
Any process that modulates the frequency, rate or extent of the calcineurin-NFAT signaling cascade.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Vocalization behavior GO:0071625
The behavior in which an organism produces sounds by a mechanism involving its respiratory system.
|
2 | H0ZT29 (/IMP) H0ZT29 (/IMP) |
Positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway GO:0071879
Any process that activates or increases the frequency, rate or extent of the adenylate cyclase-activating adrenergic receptor protein signaling pathway. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Response to anesthetic GO:0072347
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an anesthetic stimulus. An anesthetic is a substance that causes loss of feeling, awareness, or sensation.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
2 | P18431 (/IGI) P18431 (/IGI) |
Establishment of epithelial cell planar polarity GO:0090163
The specification and formation of the polarity of an epithelial cell along the plane of the epithelial tissue.
|
2 | P18431 (/IGI) P18431 (/IGI) |
Establishment of epithelial cell planar polarity GO:0090163
The specification and formation of the polarity of an epithelial cell along the plane of the epithelial tissue.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0106071
Any process that activates or increases the frequency, rate or extent of an adenylate cyclase-activating G protein-coupled receptor signaling pathway.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Positive regulation of amyloid-beta formation GO:1902004
Any process that activates or increases the frequency, rate or extent of amyloid-beta formation.
|
2 | P49840 (/IGI) P49840 (/IGI) |
Positive regulation of amyloid-beta formation GO:1902004
Any process that activates or increases the frequency, rate or extent of amyloid-beta formation.
|
2 | P49840 (/IMP) P49840 (/IMP) |
Positive regulation of proteolysis involved in cellular protein catabolic process GO:1903052
Any process that activates or increases the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Regulation of autophagy of mitochondrion GO:1903146
Any process that modulates the frequency, rate or extent of mitochondrion degradation by an autophagic process.
|
2 | P49840 (/IMP) P49840 (/IMP) |
Positive regulation of protein targeting to mitochondrion GO:1903955
Any process that activates or increases the frequency, rate or extent of protein targeting to mitochondrion.
|
2 | P49840 (/IMP) P49840 (/IMP) |
Negative regulation of glycogen synthase activity, transferring glucose-1-phosphate GO:1904227
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen synthase activity, transferring glucose-1-phosphate.
|
2 | P49840 (/IMP) P49840 (/IMP) |
Positive regulation of ubiquitin-dependent protein catabolic process GO:2000060
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
|
2 | P18431 (/IMP) P18431 (/IMP) |
Negative regulation of dendrite development GO:2000171
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
|
2 | P18265 (/IMP) P18266 (/IMP) |
Positive regulation of glycogen (starch) synthase activity GO:2000467
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
|
2 | P49840 (/ISS) P49840 (/ISS) |
Establishment of mitotic spindle orientation GO:0000132
A cell cycle process that sets the alignment of mitotic spindle relative to other cellular structures.
|
1 | Q9U2Q9 (/IMP) |
Mitotic cytokinesis GO:0000281
A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells.
|
1 | P51136 (/IMP) |
Regulation of systemic arterial blood pressure GO:0003073
The process that modulates the force with which blood travels through the systemic arterial circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
|
1 | Q2NL51 (/IMP) |
Cardiac left ventricle morphogenesis GO:0003214
The process in which the left cardiac ventricle is generated and organized.
|
1 | Q2NL51 (/IMP) |
Establishment or maintenance of cell polarity GO:0007163
Any cellular process that results in the specification, formation or maintenance of anisotropic intracellular organization or cell growth patterns.
|
1 | P18266 (/IDA) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | P51136 (/IMP) |
Multicellular organism development GO:0007275
The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
|
1 | P51136 (/IMP) |
Germ cell development GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
1 | Q9U2Q9 (/IGI) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | P18265 (/IDA) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | P18266 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | Q2NL51 (/ISO) |
Response to zinc ion GO:0010043
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
1 | P18266 (/IDA) |
Response to lithium ion GO:0010226
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
|
1 | P18266 (/IEP) |
Positive regulation of mitochondrial membrane potential GO:0010918
Any process that activates or increases the frequency, rate or extent of establishment or extent of a mitochondrial membrane potential, the electric potential existing across any mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
1 | P18266 (/IMP) |
Response to activity GO:0014823
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus.
|
1 | P18266 (/IEP) |
CAMP-mediated signaling GO:0019933
Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
|
1 | P51136 (/IMP) |
Signaling GO:0023052
The entirety of a process in which information is transmitted within a biological system. This process begins with an active signal and ends when a cellular response has been triggered.
|
1 | Q10452 (/NAS) |
Establishment of cell polarity GO:0030010
The specification and formation of anisotropic intracellular organization or cell growth patterns.
|
1 | P18266 (/IDA) |
Establishment of cell polarity GO:0030010
The specification and formation of anisotropic intracellular organization or cell growth patterns.
|
1 | P18266 (/IMP) |
Maintenance of cell polarity GO:0030011
The maintenance of established anisotropic intracellular organization or cell growth patterns.
|
1 | P18266 (/IMP) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
1 | P51136 (/IMP) |
Regulation of cell adhesion GO:0030155
Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix.
|
1 | P51136 (/TAS) |
Sporulation resulting in formation of a cellular spore GO:0030435
The process in which a relatively unspecialized cell acquires the specialized features of a cellular spore, a cell form that can be used for dissemination, for survival of adverse conditions because of its heat and dessication resistance, and/or for reproduction.
|
1 | P51136 (/IMP) |
Regulation of axon extension GO:0030516
Any process that modulates the rate, direction or extent of axon extension.
|
1 | P18266 (/IMP) |
Aggregation involved in sorocarp development GO:0031152
The process whose specific outcome is the progression of the aggregate over time, from its formation to the point when a slug is formed. Aggregate development begins in response to starvation and continues by the chemoattractant-mediated movement of cells toward each other. The aggregate is a multicellular structure that gives rise to the slug.
|
1 | P51136 (/IMP) |
Culmination involved in sorocarp development GO:0031154
The process whose specific outcome is the progression of the culminant over time, from its formation to the mature structure. Culmination begins with a morphogenetic change of the finger-like or migratory slug giving rise to an organized structure containing a stalk and a sorus. This process is the final stage of sorocarp development.
|
1 | P51136 (/IMP) |
Sorocarp morphogenesis GO:0031288
The process in which the sorocarp is generated and organized. An example of this process is found in Dictyostelium discoideum.
|
1 | P51136 (/IMP) |
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | Q2NL51 (/ISO) |
TOR signaling GO:0031929
A series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors.
|
1 | P51136 (/IMP) |
Negative regulation of TOR signaling GO:0032007
Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling.
|
1 | Q2NL51 (/IMP) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
1 | P18266 (/IEP) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
1 | P18266 (/IEP) |
Cellular response to insulin stimulus GO:0032869
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
1 | Q2NL51 (/ISO) |
Regulation of mitotic sister chromatid segregation GO:0033047
Any process that modulates the frequency, rate or extent of sister chromatid segregation during mitosis.
|
1 | Q10452 (/IMP) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
1 | Q2NL51 (/IDA) |
Positive regulation of osteoblast proliferation GO:0033690
Any process that activates or increases the rate or extent of osteoblast proliferation.
|
1 | P18266 (/IMP) |
Negative regulation of smooth muscle cell apoptotic process GO:0034392
Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process.
|
1 | P18266 (/IMP) |
Hepatic stellate cell activation GO:0035733
A change in the morphology or behavior of a hepatic stellate cell resulting from exposure to a cytokine, chemokine, hormone, cellular ligand or soluble factor.
|
1 | P18266 (/IMP) |
Cellular response to erythropoietin GO:0036018
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an erythropoietin stimulus.
|
1 | P18266 (/IEP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P18266 (/IEP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
1 | P18266 (/IDA) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
1 | P18266 (/IMP) |
Regulation of GTPase activity GO:0043087
Any process that modulates the rate of GTP hydrolysis by a GTPase.
|
1 | P51136 (/IMP) |
Proteasome-mediated ubiquitin-dependent protein catabolic process GO:0043161
The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
|
1 | Q2NL51 (/IDA) |
Chemotaxis to folate GO:0043326
The directed movement of a motile cell or organism in response to the presence of folate.
|
1 | P51136 (/IMP) |
Chemotaxis to cAMP GO:0043327
The directed movement of a motile cell or organism in response to the presence of 3',5'-cAMP.
|
1 | P51136 (/IMP) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
1 | P18266 (/IMP) |
Regulation of myosin II filament assembly GO:0043520
Any process that modulates the frequency, rate or extent of the formation of a bipolar filament composed of myosin II molecules.
|
1 | P51136 (/IMP) |
Engulfment of apoptotic cell GO:0043652
The removal of the apoptotic cell by phagocytosis, by a neighboring cell or by a phagocyte.
|
1 | Q9U2Q9 (/IMP) |
Regulation of osteoblast differentiation GO:0045667
Any process that modulates the frequency, rate or extent of osteoblast differentiation.
|
1 | P18266 (/IMP) |
Positive regulation of osteoclast differentiation GO:0045672
Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
|
1 | P18266 (/IMP) |
Positive regulation of heart contraction GO:0045823
Any process that activates or increases the frequency, rate or extent of heart contraction.
|
1 | Q2NL51 (/IMP) |
Regulation of protein kinase activity GO:0045859
Any process that modulates the frequency, rate or extent of protein kinase activity.
|
1 | P51136 (/IMP) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | Q91757 (/IDA) |
Negative regulation of glucose import GO:0046325
Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
1 | Q2NL51 (/ISO) |
Negative regulation of insulin receptor signaling pathway GO:0046627
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
|
1 | Q2NL51 (/ISO) |
Positive regulation of protein export from nucleus GO:0046827
Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm.
|
1 | P51136 (/IMP) |
Bone remodeling GO:0046849
The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
|
1 | P18266 (/IDA) |
Phosphatidylinositol-mediated signaling GO:0048015
A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
|
1 | P51136 (/IMP) |
Regulation of neuronal synaptic plasticity GO:0048168
A process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
|
1 | P18266 (/IMP) |
Male gamete generation GO:0048232
Generation of the male gamete; specialised haploid cells produced by meiosis and along with a female gamete takes part in sexual reproduction.
|
1 | P83101 (/IMP) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
1 | P18266 (/IMP) |
Regulation of dendrite morphogenesis GO:0048814
Any process that modulates the frequency, rate or extent of dendrite morphogenesis.
|
1 | P18266 (/IMP) |
Regulation of axonogenesis GO:0050770
Any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron.
|
1 | P18266 (/IMP) |
Negative regulation of dendrite morphogenesis GO:0050774
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis.
|
1 | P18266 (/IMP) |
Negative regulation of nitric-oxide synthase activity GO:0051001
Any process that stops or reduces the activity of the enzyme nitric-oxide synthase.
|
1 | P18266 (/IMP) |
Positive regulation of chromosome segregation GO:0051984
Any process that activates or increases the frequency, rate or extent of chromosome segregation, the process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets.
|
1 | Q10452 (/IMP) |
Wnt signaling pathway, regulating spindle positioning GO:0060069
The series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell and ending with the positioning of the mitotic spindle.
|
1 | Q9U2Q9 (/IMP) |
Regulation of aggregation involved in sorocarp development GO:0060176
Any process that modulates the frequency, rate or extent of aggregation during sorocarp development. Aggregation involved in sorocarp development is the process whose specific outcome is the progression of the aggregate over time, from its formation to the point when a slug is formed. Aggregate development begins in response to starvation and continues by the chemoattractant-mediated movement of cells toward each other. The aggregate is a multicellular structure that gives rise to the slug.
|
1 | P51136 (/IMP) |
Cell growth involved in cardiac muscle cell development GO:0061049
The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
|
1 | P18266 (/IDA) |
Negative regulation of cell growth involved in cardiac muscle cell development GO:0061052
Any process that decreases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.
|
1 | Q2NL51 (/IMP) |
Regulation of positive chemotaxis to cAMP GO:0061118
Any process that modulates the rate, frequency, or extent of directed movement of a motile cell or organism up a concentration gradient of 3',5'-cAMP.
|
1 | P51136 (/IMP) |
Cellular response to hydrogen peroxide GO:0070301
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | P18266 (/IEP) |
Left/right axis specification GO:0070986
The establishment, maintenance and elaboration of the left/right axis. The left/right axis is defined by a line that runs orthogonal to both the anterior/posterior and dorsal/ventral axes. Each side is defined from the viewpoint of the organism rather of the observer (as per anatomical axes).
|
1 | Q9U2Q9 (/IMP) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P18266 (/IDA) |
Cellular response to iron(II) ion GO:0071282
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(II) ion stimulus.
|
1 | P18266 (/IEP) |
Cellular response to lithium ion GO:0071285
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
|
1 | Q2NL51 (/IDA) |
Cellular response to lithium ion GO:0071285
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
|
1 | P18266 (/IEP) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
1 | Q2NL51 (/IDA) |
Response to epinephrine GO:0071871
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.
|
1 | P18266 (/IEP) |
Positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway GO:0071879
Any process that activates or increases the frequency, rate or extent of the adenylate cyclase-activating adrenergic receptor protein signaling pathway. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.
|
1 | Q2NL51 (/IMP) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
1 | Q91757 (/IDA) |
Positive regulation of osteoclast proliferation GO:0090290
Any process that increases the rate, frequency, or extent of the multiplication or reproduction of osteoclasts, resulting in the expansion of an osteoclast cell population.
|
1 | P18266 (/IMP) |
Hepatocyte apoptotic process GO:0097284
Any apoptotic process in a hepatocyte, the main structural component of the liver.
|
1 | P18266 (/IDA) |
Regulation of neurotransmitter receptor localization to postsynaptic specialization membrane GO:0098696
Any process that modulates the frequency, rate or extent of neurotransmitter receptor localization to postsynaptic specialization membrane.
|
1 | P18266 (/IDA) |
Regulation of neurotransmitter receptor localization to postsynaptic specialization membrane GO:0098696
Any process that modulates the frequency, rate or extent of neurotransmitter receptor localization to postsynaptic specialization membrane.
|
1 | P18266 (/IMP) |
Regulation of modification of postsynaptic structure GO:0099159
Any process that modulates the frequency, rate or extent of modification of postsynaptic structure.
|
1 | P18266 (/IDA) |
Regulation of modification of postsynaptic structure GO:0099159
Any process that modulates the frequency, rate or extent of modification of postsynaptic structure.
|
1 | P18266 (/IMP) |
Neuron projection organization GO:0106027
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a prolongation or process extending from a neuron, e.g. an axon, or a dendrite.
|
1 | P18266 (/IMP) |
Positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0106071
Any process that activates or increases the frequency, rate or extent of an adenylate cyclase-activating G protein-coupled receptor signaling pathway.
|
1 | Q2NL51 (/IMP) |
Negative regulation of protein localization to nucleus GO:1900181
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to nucleus.
|
1 | P18266 (/IMP) |
Positive regulation of engulfment of apoptotic cell GO:1901076
Any process that activates or increases the frequency, rate or extent of engulfment of apoptotic cell.
|
1 | Q9U2Q9 (/IMP) |
Negative regulation of protein acetylation GO:1901984
Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation.
|
1 | P18266 (/IMP) |
Positive regulation of amyloid-beta formation GO:1902004
Any process that activates or increases the frequency, rate or extent of amyloid-beta formation.
|
1 | Q2NL51 (/ISO) |
Response to L-glutamate GO:1902065
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-glutamate stimulus.
|
1 | P18266 (/IEP) |
Positive regulation of mitotic spindle elongation GO:1902846
Any process that activates or increases the frequency, rate or extent of mitotic spindle elongation.
|
1 | P51136 (/IMP) |
Regulation of autophagy of mitochondrion GO:1903146
Any process that modulates the frequency, rate or extent of mitochondrion degradation by an autophagic process.
|
1 | Q2NL51 (/ISO) |
Cellular response to dopamine GO:1903351
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dopamine stimulus.
|
1 | P18266 (/IEP) |
Positive regulation of distal tip cell migration GO:1903356
Any process that activates or increases the frequency, rate or extent of distal tip cell migration.
|
1 | Q9U2Q9 (/IMP) |
Positive regulation of protein targeting to mitochondrion GO:1903955
Any process that activates or increases the frequency, rate or extent of protein targeting to mitochondrion.
|
1 | Q2NL51 (/ISO) |
Negative regulation of glycogen synthase activity, transferring glucose-1-phosphate GO:1904227
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen synthase activity, transferring glucose-1-phosphate.
|
1 | Q2NL51 (/ISO) |
Negative regulation of dopaminergic neuron differentiation GO:1904339
Any process that stops, prevents or reduces the frequency, rate or extent of dopaminergic neuron differentiation.
|
1 | P18266 (/IMP) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
1 | P18266 (/IDA) |
Regulation of protein localization to cell cortex GO:1904776
Any process that modulates the frequency, rate or extent of protein localization to cell cortex.
|
1 | P51136 (/IMP) |
Positive regulation of protein localization to kinetochore GO:1905342
Any process that activates or increases the frequency, rate or extent of protein localization to kinetochore.
|
1 | Q10452 (/IMP) |
Response to insulin-like growth factor stimulus GO:1990418
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
1 | P18266 (/IEP) |
Response to ultrasound GO:1990478
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultrasonic stimulus.
|
1 | P18266 (/IEP) |
Response to angiotensin GO:1990776
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen.
|
1 | P18266 (/IEP) |
Positive regulation of excitatory postsynaptic potential GO:2000463
Any process that enhances the establishment or increases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
|
1 | P18266 (/IMP) |
Positive regulation of glycogen (starch) synthase activity GO:2000467
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
|
1 | Q2NL51 (/IMP) |
Positive regulation of DNA biosynthetic process GO:2000573
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
|
1 | P18266 (/IMP) |
Negative regulation of neuron migration GO:2001223
Any process that stops, prevents or reduces the frequency, rate or extent of neuron migration.
|
1 | P18266 (/IMP) |
There are 67 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
36 |
P18266 (/IDA)
P18431 (/IDA)
P18431 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(26 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
24 |
P18265 (/TAS)
P18266 (/TAS)
P18431 (/TAS)
P18431 (/TAS)
P49840 (/TAS)
P49840 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(14 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
19 |
P18265 (/IDA)
P18266 (/IDA)
P18431 (/IDA)
P18431 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(9 more) |
Beta-catenin destruction complex GO:0030877
A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome.
|
19 |
P18266 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(9 more) |
Glutamatergic synapse GO:0098978
A synapse that uses glutamate as a neurotransmitter.
|
19 |
P18266 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(9 more) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
18 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(8 more) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
17 |
P18431 (/IDA)
P18431 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(7 more) |
Beta-catenin destruction complex GO:0030877
A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome.
|
17 |
P49840 (/TAS)
P49840 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(7 more) |
Glutamatergic synapse GO:0098978
A synapse that uses glutamate as a neurotransmitter.
|
16 |
P18266 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
P49841 (/IMP)
(6 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
15 |
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
P49841 (/IDA)
(5 more) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Dendrite GO:0030425
A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
|
15 |
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
P49841 (/ISS)
(5 more) |
Glutamatergic synapse GO:0098978
A synapse that uses glutamate as a neurotransmitter.
|
15 |
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
P49841 (/EXP)
(5 more) |
Wnt signalosome GO:1990909
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
|
15 |
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
P49841 (/TAS)
(5 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
7 | P18266 (/ISS) P83101 (/ISS) Q5YJC2 (/ISS) Q9U2Q9 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
5 | P18266 (/ISS) Q5YJC2 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
4 | P18266 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Microtubule GO:0005874
Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle.
|
4 | Q2NL51 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
4 | Q5YJC2 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
4 | Q5YJC2 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) Q9WV60 (/ISS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
3 | P18431 (/HDA) P18431 (/HDA) Q10452 (/HDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
3 | P18266 (/IDA) P18431 (/IDA) P18431 (/IDA) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Dendrite GO:0030425
A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Growth cone GO:0030426
The migrating motile tip of a growing neuron projection, where actin accumulates, and the actin cytoskeleton is the most dynamic.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Beta-catenin destruction complex GO:0030877
A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Dendritic spine GO:0043197
A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including \thin\, \stubby\, \mushroom\, and \branched\, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Dendritic shaft GO:0043198
Cylindric portion of the dendrite, directly stemming from the perikaryon, and carrying the dendritic spines.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Membrane-bounded organelle GO:0043227
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Cell body GO:0044297
The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Mitotic spindle GO:0072686
A spindle that forms as part of mitosis. Mitotic and meiotic spindles contain distinctive complements of proteins associated with microtubules.
|
3 | P18431 (/IDA) P18431 (/IDA) P51136 (/IDA) |
Schaffer collateral - CA1 synapse GO:0098685
A synapse between the Schaffer collateral axon of a CA3 pyramidal cell and a CA1 pyramidal cell.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Glutamatergic synapse GO:0098978
A synapse that uses glutamate as a neurotransmitter.
|
3 | Q9WV60 (/ISO) Q9WV60 (/ISO) Q9WV60 (/ISO) |
Ribonucleoprotein complex GO:1990904
A macromolecular complex containing both protein and RNA molecules.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Wnt signalosome GO:1990909
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
|
3 | Q9WV60 (/IDA) Q9WV60 (/IDA) Q9WV60 (/IDA) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
2 | P18431 (/HDA) P18431 (/HDA) |
Microtubule GO:0005874
Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle.
|
2 | P18265 (/IDA) P18266 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | P18431 (/TAS) P18431 (/TAS) |
Beta-catenin destruction complex GO:0030877
A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome.
|
2 | P49840 (/NAS) P49840 (/NAS) |
Neuromuscular junction GO:0031594
The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Female germline ring canal GO:0035324
An intercellular bridge that connects the germline cells of a female cyst.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
2 | P49840 (/NAS) P49840 (/NAS) |
Fusome GO:0045169
A large intracellular spectrin-rich structure that has been found in insect germline cells and mammalian hematopoietic cells. The fusome is an elongated, branched structure, formed from the spherical spectrosome organelle.
|
2 | P18431 (/IDA) P18431 (/IDA) |
Apical dendrite GO:0097440
A dendrite that emerges near the apical pole of a neuron. In bipolar neurons, apical dendrites are located on the opposite side of the soma from the axon.
|
2 | P49840 (/NAS) P49840 (/NAS) |
Proximal dendrite GO:1990635
The dendrite of the dendritic tree that is closest to the neuronal cell body (the soma).
|
2 | P49840 (/NAS) P49840 (/NAS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | Q10452 (/HDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
1 | P18266 (/IDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | P18266 (/IDA) |
Dendrite GO:0030425
A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
|
1 | P18266 (/IDA) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
1 | P18266 (/IDA) |
Dendritic spine GO:0043197
A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including \thin\, \stubby\, \mushroom\, and \branched\, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity.
|
1 | P18266 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | P18266 (/IDA) |
Schaffer collateral - CA1 synapse GO:0098685
A synapse between the Schaffer collateral axon of a CA3 pyramidal cell and a CA1 pyramidal cell.
|
1 | P18266 (/IDA) |
Schaffer collateral - CA1 synapse GO:0098685
A synapse between the Schaffer collateral axon of a CA3 pyramidal cell and a CA1 pyramidal cell.
|
1 | P18266 (/IMP) |